ID: ALA5205761

Max Phase: Preclinical

Molecular Formula: C19H19N5O2

Molecular Weight: 349.39

Associated Items:

Representations

Canonical SMILES:  N#Cc1cc(-c2ncc3c(=O)[nH][nH]c3n2)ccc1OCC1CCCCC1

Standard InChI:  InChI=1S/C19H19N5O2/c20-9-14-8-13(17-21-10-15-18(22-17)23-24-19(15)25)6-7-16(14)26-11-12-4-2-1-3-5-12/h6-8,10,12H,1-5,11H2,(H2,21,22,23,24,25)

Standard InChI Key:  RGDYQVIELSOMJA-UHFFFAOYSA-N

Associated Targets(Human)

Xanthine dehydrogenase 1038 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 349.39Molecular Weight (Monoisotopic): 349.1539AlogP: 3.14#Rotatable Bonds: 4
Polar Surface Area: 107.45Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.51CX Basic pKa: 3.71CX LogP: 4.16CX LogD: 4.16
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.75Np Likeness Score: -1.15

References

1. Zhao J, Mao Q, Lin F, Zhang B, Sun M, Zhang T, Wang S..  (2022)  Intramolecular hydrogen bond interruption and scaffold hopping of TMC-5 led to 2-(4-alkoxy-3-cyanophenyl)pyrimidine-4/5-carboxylic acids and 6-(4-alkoxy-3-cyanophenyl)-1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-ones as potent pyrimidine-based xanthine oxidase inhibitors.,  229  [PMID:34992040] [10.1016/j.ejmech.2021.114086]

Source